{"id":469906,"date":"2021-04-01T11:10:21","date_gmt":"2021-04-01T15:10:21","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=469906"},"modified":"2021-04-01T11:10:21","modified_gmt":"2021-04-01T15:10:21","slug":"ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/","title":{"rendered":"Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">PROVIDENCE, R.I.<\/span>, <span class=\"xn-chron\">March 31, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0Ximedica today announced a partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of the Defense Advanced Research Projects Agency&#8217;s (DARPA) Nucleic Acids On-Demand World-Wide (NOW) Program. Integrating Moderna&#8217;s proprietary mRNA technology with Ximedica&#8217;s instrument design and engineering expertise, both teams will work closely together in an effort to meet capability expectations set out by the DARPA program over the 4-year partnership. As part of the agreement, Ximedica will receive up to <span class=\"xn-money\">$11 million<\/span> in funding. <\/p>\n<p>DARPA&#8217;s Nucleic Acids On-Demand World-Wide initiative aims to develop a mobile, just-in-time manufacturing platform that quickly diagnoses pathogen threats and provides medical countermeasures to deliver pandemic prevention treatments in-field. The resulting Good Manufacturing Practice (GMP) quality mRNA vaccines and therapeutics are intended to deliver near-instantaneous protections to both military personnel and local populations. The design envisions a manufacturing unit capable of producing hundreds of doses of medicines in a matter of days in a 6-foot x 6-foot x 6-foot (<span class=\"xn-money\">1.8m<\/span> x <span class=\"xn-money\">1.8m<\/span> x <span class=\"xn-money\">1.8m<\/span>) container in remote locations around the world. <\/p>\n<p>&#8220;<i>Ximedica is honored to partner with Moderna on this very important DARPA NOW project. Together, we will work towards creating an innovative, deployable, robust prototype solution that can respond quickly to future pathogen outbreaks at their source, anywhere on the planet.<\/i>&#8221; <span class=\"xn-person\">Fernando Oliveira<\/span>, VP Strategic Development Diagnostics <\/p>\n<p>About Ximedica <br \/>Ximedica designs and develops healthcare products through world class engineering to manufacturing. We stay flexible and accountable to create products that are innovative, easy to use, and commercially viable.<\/p>\n<p>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE27551&amp;sd=2021-04-01\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines-301260834.html\">http:\/\/www.prnewswire.com\/news-releases\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines-301260834.html<\/a><\/p>\n<p>SOURCE  Ximedica<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NE27551&amp;Transmission_Id=202104011107PR_NEWS_USPR_____NE27551&amp;DateId=20210401\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire PROVIDENCE, R.I., March 31, 2021 \/PRNewswire\/ &#8212;\u00a0Ximedica today announced a partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of the Defense Advanced Research Projects Agency&#8217;s (DARPA) Nucleic Acids On-Demand World-Wide (NOW) Program. Integrating Moderna&#8217;s proprietary mRNA technology with Ximedica&#8217;s instrument design and engineering expertise, both teams will work closely together in an effort to meet capability expectations set out by the DARPA program over the 4-year partnership. As part of the agreement, Ximedica will receive up to $11 million in funding. DARPA&#8217;s Nucleic Acids On-Demand World-Wide initiative aims to develop a mobile, just-in-time manufacturing platform that quickly diagnoses pathogen threats and provides medical countermeasures to deliver &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-469906","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire PROVIDENCE, R.I., March 31, 2021 \/PRNewswire\/ &#8212;\u00a0Ximedica today announced a partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of the Defense Advanced Research Projects Agency&#8217;s (DARPA) Nucleic Acids On-Demand World-Wide (NOW) Program. Integrating Moderna&#8217;s proprietary mRNA technology with Ximedica&#8217;s instrument design and engineering expertise, both teams will work closely together in an effort to meet capability expectations set out by the DARPA program over the 4-year partnership. As part of the agreement, Ximedica will receive up to $11 million in funding. DARPA&#8217;s Nucleic Acids On-Demand World-Wide initiative aims to develop a mobile, just-in-time manufacturing platform that quickly diagnoses pathogen threats and provides medical countermeasures to deliver &hellip; Continue reading &quot;Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-01T15:10:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE27551&amp;sd=2021-04-01\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines\",\"datePublished\":\"2021-04-01T15:10:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\\\/\"},\"wordCount\":293,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE27551&amp;sd=2021-04-01\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\\\/\",\"name\":\"Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE27551&amp;sd=2021-04-01\",\"datePublished\":\"2021-04-01T15:10:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE27551&amp;sd=2021-04-01\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE27551&amp;sd=2021-04-01\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/","og_locale":"en_US","og_type":"article","og_title":"Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines - Market Newsdesk","og_description":"PR Newswire PROVIDENCE, R.I., March 31, 2021 \/PRNewswire\/ &#8212;\u00a0Ximedica today announced a partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of the Defense Advanced Research Projects Agency&#8217;s (DARPA) Nucleic Acids On-Demand World-Wide (NOW) Program. Integrating Moderna&#8217;s proprietary mRNA technology with Ximedica&#8217;s instrument design and engineering expertise, both teams will work closely together in an effort to meet capability expectations set out by the DARPA program over the 4-year partnership. As part of the agreement, Ximedica will receive up to $11 million in funding. DARPA&#8217;s Nucleic Acids On-Demand World-Wide initiative aims to develop a mobile, just-in-time manufacturing platform that quickly diagnoses pathogen threats and provides medical countermeasures to deliver &hellip; Continue reading \"Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-01T15:10:21+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE27551&amp;sd=2021-04-01","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines","datePublished":"2021-04-01T15:10:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/"},"wordCount":293,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE27551&amp;sd=2021-04-01","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/","name":"Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE27551&amp;sd=2021-04-01","datePublished":"2021-04-01T15:10:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE27551&amp;sd=2021-04-01","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE27551&amp;sd=2021-04-01"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ximedica-announces-partnership-with-moderna-inc-nasdaq-mrna-to-develop-a-prototype-for-rapid-mobile-manufacturing-of-vaccines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/469906","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=469906"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/469906\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=469906"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=469906"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=469906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}